Compared to Estimates, Tempus (TEM) Q2 Earnings: A Look at Key Metrics

Core Insights - Tempus AI reported $314.64 million in revenue for the quarter ended June 2025, marking an 89.6% year-over-year increase [1] - The EPS for the same period was -$0.22, an improvement from -$0.63 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $299.32 million by 5.12% [1] - The company also delivered an EPS surprise of 4.35%, compared to the consensus estimate of -$0.23 [1] Financial Performance Metrics - Net Revenue from Data and Services was $72.79 million, slightly below the four-analyst average estimate of $73.93 million [4] - Net Revenue from Genomics reached $241.84 million, surpassing the four-analyst average estimate of $224.3 million [4] - Non-GAAP Gross Profit from Genomics was $143.76 million, exceeding the three-analyst average estimate of $129.5 million [4] - Non-GAAP Gross Profit from Data and Services was $53.76 million, slightly above the average estimate of $53.46 million based on three analysts [4] Stock Performance - Tempus shares have returned -1.4% over the past month, while the Zacks S&P 500 composite increased by 1.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]